One study illustrated how individuals with SM often carry secondary mutations associated with myeloid neoplasms, such as JAK2 V617F, TP53, SRSF2, ASXL1, RUNX1, or TET2 [3]. This evidence concerns the gene ASXL1 and systemic mastocytosis.